Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH)

Japanese Journal of Cancer Research

Volumn 89, Issue 12, 1998, Pages 1352-1357

  Ono, Koji ^a   Kinashi, Yuko ^a   Masunaga, Shin Ichiro ^a   Suzuki, Minoru ^a   Takagaki, Masao ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

BNCT; Borocaptate sodium; Electroporation

Indexed keywords

BORIC ACID; BOROCAPTATE; BORON 10; DEUTERIUM OXIDE;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL GROWTH; CELL KILLING; CELL MEMBRANE PERMEABILITY; COLONY FORMATION; CULTURE MEDIUM; DRUG SELECTIVITY; ELECTROPORATION; JAPAN; MOUSE; NEUTRON; NEUTRON CAPTURE THERAPY; NEUTRON RADIATION; NONHUMAN; PRIORITY JOURNAL; REACTOR; TISSUE DISTRIBUTION; TUMOR; TUMOR CELL LINE; UNIVERSITY;

EID: 0032448968     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00533.x     Document Type: Article

References (16)

1. Barth, R. F., Soloway, A. H. and Fairchild, R. G. Boron neutron capture therapy of cancer. Cancer Res.,50, 1061-1070 (1990).
2. Wazer, D. E., Zamenhof, R. G., Harling, O. K. and Madoc-Jones, H. Boron neutron capture therapy. In "Radiation Oncology Technology and Biology," ed. P. M. March and J. S. Loeffler, pp. 167-191(1994). W. B. Saunders, Philadelphia.
3. Hatanaka, H. Boron neutron capture therapy for tumors. In "Glioma," ed. A. B. M. F. Karim and E. R. Law, pp. 233-249 (1991). Springer-Verlag, Berlin and Heidelberg.
4. Zimmermann, U., Vienken, J. and Pilwat, G. Development of drug carrier systems: electric field induced effects in cell membranes. J. Electroanal. Chem.,116, 553-574 (1980).
5. 10B concentrations in tissue for neutron capture therapy by prompt gamma-ray spectrometry. Nucl. Iustrum. Meth.,204, 525-531 (1983).
6. Ono, K., Masunaga, S., Kinashi, Y., Takagaki, M., Akaboshi, M., Kobayashi, T. and Akuta, K. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys.,34, 1081-1086 (1996).
7. Hatanaka, H. Introduction. In "Boron-neutron Capture Therapy for Tumors," ed. H. Hatanaka, pp. 1-28 (1986). Nishimura, Niigata.
8. Stragliotto, G. and Fankhauser, H. Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors. Neurosurgery, 36, 285-293 (1995).
9. 11SH in patients with glioblastoma. Cancer Res.,54, 6318-6320 (1994).
10. 11SH) on glioblastoma. J. Neurooncol, 35, 177-185 (1997).
11. Fairchild, R. G., Kahl, S. B., Laster, B. H., Kalef-Ezra, J. and Popenoe, E. A. In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides. Cancer Res.,50, 4860-4865 (1990).
12. Soloway, A. H., Hatanaka, H. and Davis, M. A. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. J. Med. Chem.,10, 714-717 (1967).
13. Yu, N. Y. and Brown, J. M. Depletion of glutathione in vitro as a method of improving the therapeutic ratio of misonidazole and SR 2508. Int. J. Radiat. Oncol. Biol. Phys., 10, 1265-1269 (1984).
14. Ceberg, C. P., Brun, A., Mir, L. M., Persson, B. R. R. and Salford, L. G. Enhanced boron uptake in RG 2 rat glioma by electropermeabilization in vivo - a new possibility in boron neutron capture therapy. Anticancer Drugs, 5, 463-466 (1994).
15. Kambe, M., Ioritani, N., Shirai, S., Kambe, K., Kuwahara, M., Arita, D., Funato, T., Shimodaira, H., Gamo, M., Orikasa, S. and Kanemaru, R. Enhancement of chemotherapeutic effects with focused shock wave: extracorporeal shock wave chemotherapy (ESWC). In Vivo, 10, 369-376 (1996).
16. Kambe, M., Arita, D., Kikuchi, H., Funato, T., Tezuka, F., Gamo, M., Murakawa, Y. and Kanemaru, R. Enhancement of the efficiency of anticancer drugs with electroporation: successful electrochemotherapy against gastric cancer cell line in vivo and in vitro. Int. J. Clin. Oncol.,2, 111-117 (1997).